Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Evonik to Restructure Keto and Pharma Amino Acid Business
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Rommelag CDMO
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Nipro Launches D2F Glass Vials Using Stevanato's EZ-fill Technology
Thermo Fisher Scientific to Leverage DHL Express GoGreen Plus Service
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Pharma Matters Q&A: Rising Above the Rest
Avara Highlights Recent Expansions and Core Capabilities
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Arbele Enters AI Alliances in Precision Oncology and Manufacturing
Panthera Biopartners Joins Parexel Site Alliance Vaccine Network
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Rottendorf Pharma Selects ValGenesis VLMS
FDA sIRB Mandate: A Chance to Reassess Site Performance
Rottendorf Pharma Selects ValGenesis’ VLMS
U.S. House of Representatives Passes the BIOSECURE Act
Post-COVID Trends in Biopharma Contract Manufacturing
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
LOTTE BIOLOGICS
Vetter Pharma International
UBI Pharma Inc.
BioTechnique
INCOG BioPharma Services
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
LOTTE BIOLOGICS
Vetter Pharma International
UBI Pharma Inc.
BioTechnique
INCOG BioPharma Services
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Financial Reports
All News
Bio News
Breaking News
Collaborations & Alliances
CRO News
Custom Sourcing News
Financial Reports
Industry News
Packaging & Tracking
Pharma Matters Q&A
Promotions & Moves
Reader Showcase
Trials & Filings
VideoBites
Breaking News
|
Financial Reports
Moderna 2Q Revenues Tumble
Reports loss of $1.3 billion in the quarter.
08.05.24
Breaking News
|
Financial Reports
Piramal Pharma Revenue Increases 12% YoY in Q1
Its CDMO Business and India Consumer Healthcare Business both grew double digits.
07.26.24
Breaking News
|
Financial Reports
Novo Nordisk 1Q Results
Ozempic sales were DKK 29.97 billion, up 33% and Wegovy sales were DKK 9.4 billion, up 106%.
05.22.24
Breaking News
|
Financial Reports
Biogen 1Q Results
Multiple sclerosis portfolio sales and rare disease revenue down 4% in the quarter.
05.22.24
Breaking News
|
Financial Reports
Amgen 1Q Results
Horizon Therapeutics acquisition adds $914 million of sales in the quarter.
05.21.24
Breaking News
|
Financial Reports
Novartis 1Q Results
Key growth drivers include Entresto with $1.9 billion in sales, up 34%, and Cosentyx with sales of $1.3 billion, up 23%.
05.20.24
Breaking News
|
Financial Reports
Merck 1Q Results
Keytruda sales were $6.9 billion in the quarter, up 20% driven by increased global uptake in earlier-stage indications.
05.20.24
Breaking News
|
Financial Reports
Abbvie 1Q Results
Global Humira sales down 36%, while Skyrizi and Rinvoq sales were up 48% and 59%, respectively.
05.20.24
Breaking News
|
Financial Reports
Johnson & Johnson 1Q Results
Innovative Medicine sales were up 1%, while COVID-19 Vaccine sales were down 97%.
05.20.24
Breaking News
|
Financial Reports
Lilly 1Q: Mounjaro, Zepbound Drive Growth
Demand for the company's incretin medicines outpaced supply increases.
05.01.24
Breaking News
|
Financial Reports
Pfizer 1Q Revenues Down 20%
Decline in Comirnaty and Paxlovid revenues drove 19% operational decrease in revenues.
05.01.24
Financial Reports
BioNTech 4Q Earnings Hit by Drop in Covid Vax Sales
Inventory write-downs by partner Pfizer reduced revenues by €291.3 million in the quarter and €906.7 million for the year.
03.20.24
Financial Reports
Pharma & Biopharma 4Q Financials At A Glance
Steep decline in COVID product sales impacts results in the quarter.
Online Exclusives
02.27.24
Breaking News
|
Financial Reports
Moderna 4Q Results
Drop in COVID-19 vaccine sales impacts results.
02.22.24
Breaking News
|
Financial Reports
Catalent 2Q Results
Biologics revenue was $446 million in the quarter, down 23%, primarily impacted by a decline in demand for COVID-19 related programs.
02.16.24
Breaking News
|
Financial Reports
Gilead 4Q Results
Product sales were down due to lower Veklury and HIV sales, partially offset by higher Oncology sales.
02.07.24
Breaking News
|
Financial Reports
Merck 4Q Growth Driven by Oncology, Vaccines
Partially offset by a decline in virology, due to COVID-19 vaccine LAGEVRIO, and in diabetes due to JANUVIA.
02.05.24
Breaking News
|
Financial Reports
AbbVie 4Q Sales Down Due to Humira Competition
Global Humira sales were down 41% to $3.3 billion in the quarter.
02.05.24
Breaking News
|
Financial Reports
Bristol Myers Squibb 4Q Revenues up 1%
Higher sales of new product portfolio, as well as Eliquis and Opdivo sales, were partially offset by lower sales of Revlimid.
02.02.24
Breaking News
|
Financial Reports
J&J 4Q Revenues up 7%
Growth driven by DARZALEX, ERLEADA, TECVAYLI, CARVYKTI, STELARA, TREMFYA, and SPRAVATO.
02.01.24
Breaking News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
View Breaking News >
CURRENT ISSUE
September 2024
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Post-COVID Trends in Biopharma Contract Manufacturing
Pharma’s Next Frontier: GLP-1s and Other New Therapies
CEO Spotlight: Prasad Raje
HPAPIs Soar Riding the Targeted Drugs Wave
View More >